Husch Blackwell's Kimberly Chew joined the Psytelligence Podcast to explore legal developments in psychedelics including clinical research, patent pledges, second generation psychedelic drug development, and the legal fight for expanded access to psychedelics for palliative or end-of-life care. Watch the podcast on YouTube or listen via Apple Podcast.
Co-founder and co-leader of the firm’s Psychedelic and Emerging Therapies practice group, Kimberly offers clients experienced guidance through the web of legal complexities at the state and federal levels as these novel therapies proceed through the clinical trial process.